OTCM
INBP
Market cap10mUSD
Jul 10, Last price
0.34USD
1D
-0.70%
1Q
13.90%
Jan 2017
50.11%
Name
Integrated Biopharma Inc
Chart & Performance
Profile
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized healthcare providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | |
Income | |||||||||
Revenues | 50,317 -0.70% | 50,672 -9.91% | |||||||
Cost of revenue | 46,433 | 46,611 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 3,884 | 4,061 | |||||||
NOPBT Margin | 7.72% | 8.01% | |||||||
Operating Taxes | 156 | 134 | |||||||
Tax Rate | 4.02% | 3.30% | |||||||
NOPAT | 3,728 | 3,927 | |||||||
Net income | 112 -429.41% | (34) -100.89% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 13 | 4 | |||||||
BB yield | -0.20% | -0.04% | |||||||
Debt | |||||||||
Debt current | 1,904 | 1,860 | |||||||
Long-term debt | 2,644 | 4,365 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | 2,871 | 4,909 | |||||||
Cash flow | |||||||||
Cash from operating activities | 943 | 1,232 | |||||||
CAPEX | (553) | (116) | |||||||
Cash from investing activities | (553) | (111) | |||||||
Cash from financing activities | (29) | (136) | |||||||
FCF | 6,704 | 749 | |||||||
Balance | |||||||||
Cash | 1,677 | 1,316 | |||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | (32,167) | (32,279) | |||||||
Invested Capital | 54,155 | 57,008 | |||||||
ROIC | 6.71% | 7.15% | |||||||
ROCE | 17.66% | 16.42% | |||||||
EV | |||||||||
Common stock shares outstanding | 30,874 | 29,950 | |||||||
Price | 0.21 -36.60% | 0.33 -33.74% | |||||||
Market cap | 6,483 -34.64% | 9,920 -38.60% | |||||||
EV | 9,354 | 14,829 | |||||||
EBITDA | 5,105 | 5,215 | |||||||
EV/EBITDA | 1.83 | 2.84 | |||||||
Interest | 40 | ||||||||
Interest/NOPBT | 0.98% |